from web site
Sources The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research study. Accessed 5/13/2021. Corroon J, Felice JF. The Endocannabinoid System and its Modulation by Cannabidiol (CBD). Altern Ther Health Medication. 2019; 25(S2):6 -14. Cannabidiol (CBD) what we know and what we do not Harvard Health Blog. Harvard Health Blog.
Linares IM, Zuardi AW, Pereira LC, et al. . Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test. Revista brasileira de psiquiatria. 2019; 41( 1 ):9 -14. Zanelati TV, Biojone C, Moreira FA, Guimares FS, Joca SR. . Antidepressant-like effects of cannabidiol in mice: possible participation of 5-HT1A receptors. Br J Pharmacol. Workplace of the Commissioner.
FDA approves first drug consisted of an active component derived from marijuana to deal with rare, severe forms of epilepsy. U.S. Food and Drug Administration. Accessed 5/13/2021. Elms L, Shannon S, Hughes S, Lewis N. Cannabidiol in the Treatment of Trauma: A Case Series. The Journal of Alternative and Complementary Medication. Bitencourt RM, Takahashi Registered Nurse. Cannabidiol as a Healing Option for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials. Frontiers in Neuroscience. 2018; 12. Hurd YL, Spriggs S, Alishayev J, et al. Cannabidiol for the Reduction of Cue-Induced Yearning and Stress And Anxiety in Drug-Abstinent Individuals With Heroin Usage Disorder: A Double-Blind Randomized Placebo-Controlled Trial. 2019; 176(11):911 -922. Hurd YL, Yoon M, Manini AF, et al. Early Phase in the Advancement of Cannabidiolas
a Treatment for Addiction: Opioid Regression Takes Initial Spotlight. Neurotherapeutics. 2015; 12(4):807 -815. Bilsland LG, Penis JR, Pryce G, et al. Increasing cannabinoid levels by pharmacologicaland genetic manipulation delay disease progression in SOD1 mice. 2006; 20 (7):1003 -1005. Meyer T, Funke A, Mnch C, et al. Real life experience of patients with amyotrophic lateral sclerosis(ALS)in the treatment of.
spasticity utilizing tetrahydrocannabinol: cannabidiol( THC: CBD ). BMC Neurol. 2019; 19(1 ):222. Russo EB. Cannabinoids in the management of hard to treat pain. Try This (1):245 -259. Xu DH, Cullen BD,Tang M, Fang Y. Curr Pharm Biotechnol. 2020; 21(5):390 -402. Weiss L, Zeira M, Reich S, et al. Cannabidiol decreases incidence of diabetes in non-obese diabetic mice. Autoimmunity.
2006; 39(2 ):143 -151. Rajesh M, Mukhopadhyay P, Btkai S, et al. Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier interruption. American Journal of Physiology-Heart and Circulatory Physiology. 2007; 293( 1): H610-H619. Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M. Cannabinoids as unique anti-inflammatory drugs. Future Medication Chem. 2009; 1( 7):1333 -1349. Blake DR, Robson P, Ho M, Jubb.